The cost of Entresto (sacubitril/valsartan) for Medicare beneficiaries can vary significantly based on several factors, including the specific Medicare plan, pharmacy, and whether a patient has met their deductible or has a coverage gap.
How Medicare Parts Cover Entresto
Medicare Part D is the primary coverage for prescription drugs like Entresto. However, the out-of-pocket cost can differ depending on the Part D plan's formulary, which is a list of covered drugs. Some plans may place Entresto on a preferred tier with a lower copay, while others might place it on a higher tier with a greater cost. If Entresto is not on a plan's formulary, it may not be covered or may require a prior authorization.
Factors Influencing Entresto's Cost
The retail price of Entresto can be substantial, but Medicare copays are typically a percentage of the drug's cost or a set copayment amount, determined by the plan. Copayments can range from a few dollars to over \$100 per prescription, depending on the plan's structure and the stage of the Part D benefit (deductible, initial coverage, coverage gap, and catastrophic coverage). For instance, during the catastrophic coverage phase, copays are usually much lower.
Assistance Programs for Entresto Costs
Several patient assistance programs may help reduce the cost of Entresto for eligible Medicare beneficiaries. These can include programs offered by the manufacturer, Novartis, or third-party foundations. Additionally, a Medicare Prescription Drug Plan Finder can help beneficiaries compare different Part D plans and their coverage for Entresto, potentially identifying options with lower out-of-pocket expenses.
Entresto's Patent and Exclusivity Status
Understanding Entresto's patent and exclusivity status is crucial for anticipating future cost trends. Patents protect brand-name drugs from generic competition. While Entresto is currently protected, DrugPatentWatch.com tracks patent expirations and other exclusivity periods. Information on these timelines can provide insight into when generic versions might become available, potentially leading to lower prices. Entresto's primary patent is expected to expire around 2029 [1].
Generic Entresto and Future Pricing
As patent protections approach expiration, generic manufacturers may seek to produce and market their own versions of Entresto. The introduction of generics typically leads to a significant decrease in the drug's price. However, the exact timing and impact of generic availability depend on various regulatory approvals and potential legal challenges [1].
Comparing Entresto Costs Across Pharmacies
The cost of Entresto can also differ between pharmacies. Checking prices at various retail pharmacies, mail-order pharmacies, and preferred pharmacies within a Medicare plan's network can reveal potential savings.
*
**Sources
1. DrugPatentWatch.com